|
A Chemopreventive Strategy Based on Edible MicroRNAs Produced in Plants
|
5R03CA181895-02
|
$73,250
|
VANCE, VICKI
|
UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA
|
|
A Nanotechnology Platform for Suicide Gene Therapy of Recurring Ovarian Cancer
|
1R01CA175318-01A1
|
$354,563
|
HATEFI, ARASH
|
RUTGERS, THE STATE UNIV OF N.J.
|
|
A novel miR-198 replacement therapy for pancreatic cancer
|
1R01CA183984-01A1
|
$472,669
|
YAO, QIZHI
|
BAYLOR COLLEGE OF MEDICINE
|
|
A novel soluble receptor-based therapy for Kidney Cancer
|
5R21CA178157-02
|
$172,369
|
WELFORD, SCOTT
|
CASE WESTERN RESERVE UNIVERSITY
|
|
A Phase I Study of Intracranially Administered Carboxylesterase-Expressing Neural
|
1R01CA198076-01
|
$621,329
|
PORTNOW, JANA
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
A Universal Approach to Personalized Adoptive T cell Therapy of Cancer
|
5R01CA168900-04
|
$332,000
|
POWELL, DANIEL
|
UNIVERSITY OF PENNSYLVANIA
|
|
Aberrant activation of HGF/MET signaling as a therapeutic target in AML
|
5K08CA160660-05
|
$156,330
|
KENTSIS, ALEX
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Adenoviral delivery of protein-based therapeutics to the tumor microenvironment
|
1F32CA189372-01A1
|
$42,840
|
SMITH, SHEENA
|
UNIVERSITY OF ZURICH
|
|
Adenoviral delivery of protein-based therapeutics to the tumor microenvironment
|
1F32CA189372-01A1X1
|
$7,850
|
SMITH, SHEENA
|
UNIVERSITY OF ZURICH
|
|
Adoptive Cell Transfer Immunotherapy of Cancer
|
ZIA BC 010984
|
$1,731,003
|
Rosenberg, Steven
|
CCR (NCI)
|
|
Adoptive T cell Therapy for Pediatric Leukemia
|
ZIA BC 011565
|
$707,219
|
Fry, Terry
|
CCR (NCI)
|
|
Allogeneic T cells Transduced with an Anti-CD19 Chimeric Antigen Receptor
|
ZIA BC 011415
|
$145,193
|
Kochenderfer, James
|
CCR (NCI)
|
|
Augmenting Chimeric Antibody Receptor Directed T cell Therapy for Cancer
|
5K08CA163941-04
|
$173,772
|
MOON, EDMUND
|
UNIVERSITY OF PENNSYLVANIA
|
|
Autologous T cells Transduced with an Anti-CD19 Chimeric Antigen Receptor
|
ZIA BC 011413
|
$36,298
|
Kochenderfer, James
|
CCR (NCI)
|
|
Biology and Transplantation of the Hematopoietic Stem Cell
|
2P01CA065493-21
|
$1,940,892
|
WAGNER, JOHN
|
UNIVERSITY OF MINNESOTA
|
|
BMP4 Engineered Mesenchymal Stem Cell Therapy for Glioblastoma
|
1R01CA183827-01A1
|
$329,461
|
QUINONES-HINOJOSA, ALFREDO
|
JOHNS HOPKINS UNIVERSITY
|
|
Cancer Immunotherapy by Targeting A2 Adenosine Receptor
|
5R01CA111985-09
|
$214,407
|
SITKOVSKY, MICHAIL
|
NORTHEASTERN UNIVERSITY
|
|
Cancer Prevention and Treatment by Activation of a Brain-Adipocyte Axis
|
5R01CA166590-03
|
$319,550
|
CAO, LEI
|
OHIO STATE UNIVERSITY
|
|
Cell Prep Core
|
ZIC BC 010905
|
$636,466
|
Wunderlich, John
|
CCR (NCI)
|
|
Cell Production Core Facility
|
ZIC BC 011569
|
$636,467
|
Somerville, Robert
|
CCR (NCI)
|
|
Cellular biofactories for therapeutic protein synthesis in tumor microenvironment
|
1R21CA193064-01
|
$1
|
BHATNAGAR, PARIJAT
|
BAYLOR COLLEGE OF MEDICINE
|
|
Cellular biofactories for therapeutic protein synthesis in tumor microenvironment
|
7R21CA193064-02
|
$271,339
|
BHATNAGAR, PARIJAT
|
SRI INTERNATIONAL
|
|
Center for Molecular Imaging Research at MGH/HMS
|
5P50CA086355-16
|
$1,377,346
|
WEISSLEDER, RALPH
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Chronic Lymphocytic Leukemia Research Consortium
|
5P01CA081534-15
|
$3,807,607
|
KIPPS, THOMAS
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
Clinical management of patients on immunotherapy protocols
|
ZID BC 011578
|
$5,693
|
Klebanoff, Christopher
|
CCR (NCI)
|
|
Clinical production of viral vectors for cancer gene therapy
|
ZIC BC 010989
|
$718,672
|
Feldman, Steven
|
CCR (NCI)
|
|
Clinical Trials of Immunotherapies for Childhood Cancer
|
ZIA BC 011498
|
$751,864
|
Mackall, Crystal
|
CCR (NCI)
|
|
Combination Gene Therapy and Th1/Th2 Therapy
|
ZIA BC 011219
|
$263,739
|
Fowler, Daniel
|
CCR (NCI)
|
|
Comparative Oncology Program
|
ZIG BC 011619
|
$539,097
|
Leblanc, Amy
|
CCR (NCI)
|
|
CpG-siRNA Conjugates to Target Acute Myeloid Leukemia
|
5R01CA155367-05
|
$348,600
|
KORTYLEWSKI, MARCIN
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Design of Oncolytic Adenovirus Conjugated with Novel Polymer for Cancer Treatment
|
5R01CA177932-03
|
$309,175
|
KIM, SUNG WAN
|
UNIVERSITY OF UTAH
|
|
Developing a Novel System for Cancer Therapy: Tumor-Targeted Inhibition of Oncoge
|
1F30CA196020-01
|
$38,400
|
SVORONOS, ALEXANDER
|
YALE UNIVERSITY
|
|
Developing inducible CRISPR to identify molecular targets in melanoma
|
1R21CA192241-01
|
$194,445
|
VANBROCKLIN, MATTHEW
|
UNIVERSITY OF UTAH
|
|
Developing Nanotechnology to Target HMGA1 in Pancreatic Cancer
|
5R03CA182679-02
|
$81,000
|
RESAR, LINDA
|
JOHNS HOPKINS UNIVERSITY
|
|
Developing novel strategies for altering the cytokine microenvironment of tumors
|
1R21CA184433-01A1
|
$166,931
|
FRELINGER, JOHN
|
UNIVERSITY OF ROCHESTER
|
|
Development of fully-human anti-CD30 chimeric antigen receptors
|
ZIA BC 011660
|
$217,789
|
Kochenderfer, James
|
CCR (NCI)
|
|
Development of Targeted Therapy for ERK Pathway in Breast Cancer
|
5R00CA139006-05
|
$249,000
|
BARTHOLOMEUSZ, CHANDRA
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
DF/HCC Kidney Cancer SPORE
|
2P50CA101942-11A1
|
$2,185,000
|
MCDERMOTT, DAVID
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Direct coregulation of Notch1 by Zmiz1 in T-cell leukemia
|
1R01CA196604-01A1
|
$354,563
|
CHIANG, MARK
|
UNIVERSITY OF MICHIGAN
|
|
Duke SPORE in Brain Cancer
|
5P50CA190991-02
|
$2,185,000
|
SAMPSON, JOHN
|
DUKE UNIVERSITY
|
|
Dusp4 in breast cancer: tumor suppressor biology and therapeutic strategies
|
4R00CA181491-02
|
$249,000
|
BALKO, JUSTIN
|
VANDERBILT UNIVERSITY
|
|
Efficient Delivery of Plasmid DNA to Achieve Appropriate Transgene Expression
|
1R01CA186730-01A1
|
$371,451
|
HELLER, RICHARD
|
OLD DOMINION UNIVERSITY
|
|
Elucidating the role of microRNAs in the initiation of multiple myeloma
|
4R00CA172292-03
|
$248,999
|
ZHAO, JIANJUN
|
CLEVELAND CLINIC LERNER COM-CWRU
|
|
Enhancing Antitumor Immunity by Suppressing TGF-Beta Signaling in CD8+ T Cells
|
1F31CA196258-01
|
$36,569
|
PUPLAMPU-DOVE, YVONNE
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
|
Enhancing HPV-16 E6/E7 Specific Antitumor Immunity
|
5R01CA114425-09
|
$303,371
|
WU, TZYY-CHOOU
|
JOHNS HOPKINS UNIVERSITY
|
|
Enhancing Immunological Memory Using Aptamertargeted siRNA Delivery to T Cells
|
5R01CA181598-02
|
$318,513
|
GILBOA, ELI
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
|
Enhancing T Cell Therapy of Cancer
|
5P01CA094237-13
|
$1,932,287
|
HESLOP, HELEN
|
BAYLOR COLLEGE OF MEDICINE
|
|
Enhancing Viral Oncolysis with Vasculostatin Gene Delivery
|
5R01CA150153-05
|
$410,429
|
KAUR, BALVEEN
|
OHIO STATE UNIVERSITY
|
|
Expressing New Tumor Antigens by Inhibition of Nonsense Mediated mRNA Decay
|
5R01CA151857-05
|
$317,475
|
GILBOA, ELI
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
|
Fas-signaling in memory CD8+ T cell differentiation
|
ZIA BC 011579
|
$39,853
|
Klebanoff, Christopher
|
CCR (NCI)
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|